Fibrinogen Matsumoto III: A variant with γ275 Arg→Cys (CGC→TGC). Comparison of fibrin polymerization properties with those of Matsumoto I (γ364 Asp→His) and Matsumoto II (γ308 Asn→Lys)

Thrombosis and Haemostasis

Volumn 81, Issue 5, 1999, Pages 763-766

  Terasawa, Fumiko ^a   Okumura, Nobuo ^a   Higuchi, Yumiko ^b   Ishikawa, Shinsuke ^b   Tozuka, Minoru ^b   Ishida, Fumihiro ^c   Kitano, Kiyoshi ^c   Katsuyama, Tsutomu ^d  

^a SHINSHU UNIVERSITY   (Japan)

^b SHINSHU UNIVERSITY HOSPITAL   (Japan)

^c Shinshu University   (Japan)

^d SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARAGINE; CALCIUM ION; CYSTEINE; DNA FRAGMENT; FIBRIN; FIBRINOGEN; HISTIDINE; LYSINE; SERINE;

AGED; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; FIBRIN POLYMERIZATION; HUMAN; INTRON; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN STRUCTURE; RECTUM CANCER; THROMBIN TIME;

EID: 0032934525     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614568     Document Type: Article

References (27)

1. Ebert RF. Index of Variant Human Fibrinogens. 1994 Edition, CRC Press, Inc., Boca Raton, FL, 1994.
2. Côté HCF, Lord ST, Pratt KP, γ-chain dysfibrinogenemias: molecular structure-function relationships of naturally occurring mutations in the γ chain of human fibrinogen. Blood 1998; 92: 2195-212.
3. Niwa K, Kawata Y, Madoiwa S, Takebe M, Mimuro J, Sugo T, Matsuda M, Sugimoto T, Nose K. Fibrinogen Kamogawa: a new type of γArg-275 to Ser substitution characterized by delayed fibrin gel formation. Thromb Haemost 1995; 73 (suppl): 1229.
4. Mosesson MW, Siebenlist KR. The covalent structure of factor XIIIa crosslinked fibrinogen fibrils. J Struct Biol 1995; 115: 88-101.
5. Mosesson MW, Siebenlist KR, DiOrio JP, Matsuda M, Hainfeld JF, Wall JS. The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (γ275 Arg→Cys). J Clin Invest 1995; 96: 1053-8.
6. Spraggon G, Everse SJ, Doolittle RF. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature 1997; 389: 455-62.
7. Okumura N, Furihata K, Terasawa F. Nakagoshi R, Ueno I, Katsuyama T. Fibrinogen Matsumoto I; a γ364 Asp→His (GAT→CAT) substitution associated with defective fibrin polymerization. Thromb Haemost 1996; 75: 887-91.
8. Okumura N, Furihata K, Terasawa F, Ishikawa S, Ueno I, Katsuyama T. Fibrinogen Matsumoto II: γ308 Asn→Lys (AAT→AAG) mutation associated with bleeding tendency. Br J Haematol 1996; 94: 526-8.
9. Okumura N, Gorkun OV, Lord ST. Severely impaired polymerization of recombinant fibrinogen γ-364 Asp→His, the substitution discovered in a heterozygous individual. J Biol Chem 1997; 272: 29596-601.
10. Takebe M, Soe G, Kohno I, Sugo T Matsuda M. Calcium ion-dependent monoclonal antibody against human fibrinogen; preparation, characterization, and application to fibrinogen purification. Thromb Haemost 1995; 73: 662-7.
11. Mihalyi E. Physiological studies of bovine fibrinogen. IV. ultraviolet absorption and its relation to the structure of the molecule. Biochemistry 1968; 7: 208-23.
12. Chung DW, Harris JE, Davie EW. Nucleotide sequences of the three genes coding for human fibrinogen. In; Fibrinogen, thrombosis, coagulation and fibrinolysis. Liu CY, Chien S (eds). Plenum Press, New York 1990; pp 39-48.
13. Baumann RE, Henschen AH. Human fibrinogen polymorphic site analysis by restriction endonuclease digestion and allele-specific polymerase chain reaction amplification: Identification of polymorphisms at positions Aα312 and Bβ448. Blood 1993; 82: 2117-24.
14. Terukina S, Matsuda M, Hirata H, Takeda Y, Miyata T, Takao T, Shimonishi Y. Substitution of γ Arg-275 by Cys in an abnormal fibrinogen, "fibrinogen Osaka II" Evidence for a unique solitary cystine structure at the mutation site. J Biol Chem 1988; 263: 13579-87.
15. Borrell M, Garí M, Coll I, Vallvé C, Tirado I, Soria JM, Sala N, Muñoz C, Oliver A, García A, Fontcuberta J. Abnormal polymerization and normal binding of plasminogen and t-PA in thrée new dysfibrinogenemias: Barcelona III and IV (γArg275→His) and Villajoyosa (γArg275→Cys). Blood Coagulation Fibrinolysis 1995; 6: 198-206.
16. Niwa K. Studies on the mechanism of fibrin fiber formation-comparison among three hereditary dysfibrinogens with a γArg-275 to Ser, His, or Cys mutation-. Jap J Thromb Hemosts 1997; 8: 33-43 (in Japanese).
17. Blombäck B, Hessel B, Hogg D, Therkildsen L. A two-step fibrinogen-fibrin transition in blood coagulation. Nature 1978; 275: 501-5.
18. Weisel JW, Veklich Y, Gorkun O. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots. J Mol Biol 1993; 232: 285-97.
19. Shainoff JR, Dardik BN. Fibrinopeptide B in fibrin assembly and metabolism; physiologic significance in delayed release of the peptide. Ann NY Acad Sci 1983; 408: 254-68.
20. Hasegawa N, Sasaki S. Location of the binding site "b" for lateral polymerization of fibrin. Thromb Res 1990; 57: 183-95.
21. Cierniewski CS, Budzynski AZ. Involvement of the a chain in fibrin clot formation. Effect of monoclonal antibodies. Biochemistry 1992; 31: 4248-53.
22. Gorkun OV, Veklich YI, Medved LV, Henschen AH, Weisel JW. Role of the αC domains of fibrin in clot formation. Biochemistry 1994; 33: 6986-97.
23. Okada M, Blombäck B. Calcium and fibrin gel structure. Thromb Res 1983; 29: 269-80.
24. 2+ on the structure of reptilase-derived and thrombin-derived fibrin gels. Biochem J 1986; 239: 513-6.
25. Mihalyi E. Clotting of bovine fibrinogen. Kinetic analysis of the release of fibrinopeptides by thrombin and of the calcium uptake upon clotting at high fibrinogen concentration. Biochemistry 1968; 7: 208-23.
26. Dang CV, Ebert RF, Bell WR. Localization of a fibrinogen calcium binding site between γ-subunit position 311 and 336 by terbium fluorescence. J Biol Chem 1985; 260: 9713-9.
27. Weisel JW, Nagaswami C. Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations; clot structure and assembly are kinetically controlled. Biophys J 1992; 63: 111-28.